From today's email.
We recently have revised the Medicare Supplement 2050/2070 product underwriting guidelines to include the following changes:
Additional reasons for decline:
Injections administered in the doctor's office.
Lung or respiratory disorders: use of nebulizer within the past 12 months.
Lung or respiratory disorder with tobacco use.
History of cardiovascular event (such as a heart attack, stroke or TIA) in combination with tobacco use.
If the applicant has diabetes, falls within the height/weight range for the standard rate and uses tobacco.
The applicant is prescrib
Source of insurance-forums.net
We recently have revised the Medicare Supplement 2050/2070 product underwriting guidelines to include the following changes:
Additional reasons for decline:
Injections administered in the doctor's office.
Lung or respiratory disorders: use of nebulizer within the past 12 months.
Lung or respiratory disorder with tobacco use.
History of cardiovascular event (such as a heart attack, stroke or TIA) in combination with tobacco use.
If the applicant has diabetes, falls within the height/weight range for the standard rate and uses tobacco.
The applicant is prescrib
Comments
Post a Comment